US Stock MarketDetailed Quotes

VTGN VistaGen Therapeutics

Watchlist
  • 4.7400
  • -0.0900-1.86%
Close May 1 16:00 ET
  • 4.7000
  • -0.0400-0.84%
Post 18:10 ET
128.10MMarket Cap-1601P/E (TTM)

VistaGen Therapeutics Key Stats

VistaGen Therapeutics Earnings Date

Currency: USD

Period

Q3 FY2024 Earnings

Feb 13, 2024

Revenue(YoY)

411.40K

+129.06%
EPS(YoY)

-0.22

+84.51%

Buy

Apr 30, 2024

VistaGen Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 400.000K--
--2024/Q4-- / 202.750K--
Feb 13, 20242024/Q3411.400K / 544.500K--
Nov 9, 20232024/Q2277.700K / 0.000--
Aug 10, 20232024/Q1177.600K / 0.000--
Jun 28, 20232023/Q4175.600K / 0.000--
Feb 7, 20232023/Q3179.600K / 310.000K--
Nov 10, 20222023/Q2-892.500K / 206.700K--
Aug 11, 20222023/Q1310.100K / 238.630K--
Jun 23, 20222022/Q438.900K / 253.980K--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 400.000K--
--2024/Q4-- / 202.750K--
Feb 13, 20242024/Q3411.400K / 544.500K--
Nov 9, 20232024/Q2277.700K / 0.000--
Aug 10, 20232024/Q1177.600K / 0.000--
Jun 28, 20232023/Q4175.600K / 0.000--
Feb 7, 20232023/Q3179.600K / 310.000K--
Nov 10, 20222023/Q2-892.500K / 206.700K--
Aug 11, 20222023/Q1310.100K / 238.630K--
Jun 23, 20222022/Q438.900K / 253.980K--

Unlock Free Earnings Estimates

VistaGen Therapeutics Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Apr 30, 2024

Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg